Catalent to go disposable in new plant

Catalent sees a switch from stainless steel to single-use technology for bioprocessing components in its future, with a planned move next year to a new facility in Madison, WI. The move is intended to fortify the company's credentials as a biologic contract development and manufacturing organization. Announcement

Suggested Articles

Cadila Healthcare is looking for outside manufacturing partners to add 70 million doses of its experimental COVID-19 vaccine to its arsenal.

The COVID-19 pandemic has disrupted another biopharma company's plan to launch a new medicine.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.